Clinical Trials Logo

Clinical Trial Summary

Evaluate the therapeutic effects health benefits, and immunological effect of Nigella sativa in children with beta thalassemia major.


Clinical Trial Description

Study will be carried on children patients with β- thalassemia major attending The Hematology Unit of Pediatric Department at Tanta University Hospital. patients are divided into 2 groups: patients in the control group, patients in the treatment group that will receive nigella sativa powder for 3 consecutive months. Then Evaluate the therapeutic effects health benefits, and immunological effect of Nigella sativa in children with beta thalassemia major.

Evaluate the extent of clinical improvement, reductions in serum iron and ferritin, antioxidant status, treatment of the causes of hemolysis and other therapeutic benefits of Nigella sativa in those patient. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02816957
Study type Interventional
Source Tanta University
Contact Nahed Mohamed Habas, MD
Phone 01010560350
Email nahedhablas79@gmail.com
Status Recruiting
Phase Early Phase 1
Start date June 2016
Completion date June 2017